IPHA
Innate Pharma S.A.
NASDAQ · Healthcare · Biotechnology · FR
$2.08
−1.42%Leverage
- Debt / equity
- -1.04x
- Net debt / equity
- 0.25x
- Debt / assets
- 0.36x
- Debt / EBITDA
- -0.22x
- Net debt / EBITDA
- 0.05x
Liquidity & coverage
- Current ratio
- 1.27x
- Quick ratio
- 1.27x
- Cash ratio
- 0.94x
- Interest coverage
- -29.97x
- EBITDA / interest
- -29.31x
- Working capital
- $11.7M
Cash & dividend
- FCF / debt
- -2.87x
- Cash flow / debt
- -2.85x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025